These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 4056044)

  • 1. Metabolism of pantethine in cystinosis.
    Wittwer CT; Gahl WA; Butler JD; Zatz M; Thoene JG
    J Clin Invest; 1985 Oct; 76(4):1665-72. PubMed ID: 4056044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pantethine lipomodulation: evidence for cysteamine mediation in vitro and in vivo.
    Wittwer CT; Graves CP; Peterson MA; Jorgensen E; Wilson DE; Thoene JG; Wyse BW; Windham CT; Hansen RG
    Atherosclerosis; 1987 Nov; 68(1-2):41-9. PubMed ID: 3689482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.
    Butler JD; Zatz M
    J Clin Invest; 1984 Aug; 74(2):411-6. PubMed ID: 6746900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantetheinase activity and cysteamine content in cystinotic and normal fibroblasts and leukocytes.
    Orloff S; Butler JD; Towne D; Mukherjee AB; Schulman JD
    Pediatr Res; 1981 Jul; 15(7):1063-7. PubMed ID: 7254953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantethine, a cysteamine precursor, depletes immunoreactive somatostatin and prolactin in the rat.
    Reichlin S; Bollinger-Gruber JA
    Endocrinology; 1985 Aug; 117(2):492-5. PubMed ID: 2862009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pantethine, cysteamine and pantothenic acid on open-field behavior and brain catecholamines in rats.
    Vécsei L; Widerlöv E; Alling C
    Arch Int Pharmacodyn Ther; 1989; 300():14-21. PubMed ID: 2619420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
    Smolin LA; Clark KF; Thoene JG; Gahl WA; Schneider JA
    Pediatr Res; 1988 Jun; 23(6):616-20. PubMed ID: 3393396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Mar; 124(3):397-402. PubMed ID: 2332716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.
    Thoene JG; Oshima RG; Crawhall JC; Olson DL; Schneider JA
    J Clin Invest; 1976 Jul; 58(1):180-9. PubMed ID: 932205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of intracerebroventricularly administered cysteamine and pantethine in different behavioral tests and on brain catecholamines in rats.
    Vécsei L; Alling C; Widerlöv E
    Arch Int Pharmacodyn Ther; 1990; 305():140-51. PubMed ID: 2241425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cysteamine and pantethine on open-field behavior, hypothalamic catecholamine concentrations, and somatostatin-induced barrel rotation in rats.
    Vécsei L; Alling C; Heilig M; Widerlöv E
    Pharmacol Biochem Behav; 1989 Mar; 32(3):629-35. PubMed ID: 2568000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteamine and pantethine effects on passive avoidance behavior, shuttle box learning, open-field activity, striatal catecholamines and somatostatin.
    Vécsei L; Widerlöv E; Ekman R; Alling C
    Arch Int Pharmacodyn Ther; 1989; 299():14-27. PubMed ID: 2570553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenchymal organ cystine depletion with long-term cysteamine therapy.
    Gahl WA; Charnas L; Markello TC; Bernardini I; Ishak KG; Dalakas MC
    Biochem Med Metab Biol; 1992 Dec; 48(3):275-85. PubMed ID: 1476793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pantethine depletes cystinotic fibroblasts of cystine.
    Butler JD; Zatz M
    J Pediatr; 1983 May; 102(5):796-8. PubMed ID: 6842344
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding intestinal cysteamine bitartrate absorption.
    Dohil R; Fidler M; Barshop BA; Gangoiti J; Deutsch R; Martin M; Schneider JA
    J Pediatr; 2006 Jun; 148(6):764-9. PubMed ID: 16769383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous cysteamine therapy for nephropathic cystinosis.
    Gahl WA; Ingelfinger J; Mohan P; Bernardini I; Hyman PE; Tangerman A
    Pediatr Res; 1995 Oct; 38(4):579-84. PubMed ID: 8559613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
    Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
    Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine therapy for children with nephropathic cystinosis.
    Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
    N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
    Hector E; Cairns D; Michael Wall G
    Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.